Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $105,680 | 59 | 69.1% |
| Food and Beverage | $21,387 | 756 | 14.0% |
| Travel and Lodging | $13,901 | 34 | 9.1% |
| Consulting Fee | $11,880 | 2 | 7.8% |
| Education | $178.73 | 7 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $50,768 | 233 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $50,488 | 90 | $0 (2024) |
| Alkermes, Inc. | $36,250 | 77 | $0 (2024) |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | $3,652 | 20 | $0 (2019) |
| Neurocrine Biosciences, Inc. | $2,860 | 91 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $1,415 | 47 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $1,123 | 51 | $0 (2024) |
| ITI, Inc. | $921.28 | 39 | $0 (2023) |
| LivaNova USA, Inc. | $803.29 | 14 | $0 (2024) |
| Neos Therapeutics, LP | $709.12 | 8 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $33,102 | 291 | ABBVIE INC. ($28,352) |
| 2023 | $21,541 | 253 | AbbVie Inc. ($18,071) |
| 2022 | $6,211 | 108 | ABBVIE INC. ($4,105) |
| 2021 | $18,603 | 73 | Alkermes, Inc. ($17,271) |
| 2020 | $5,226 | 23 | Alkermes, Inc. ($4,918) |
| 2019 | $21,592 | 28 | Alkermes, Inc. ($12,733) |
| 2018 | $21,281 | 43 | Otsuka America Pharmaceutical, Inc. ($19,939) |
| 2017 | $25,470 | 39 | Otsuka America Pharmaceutical, Inc. ($24,407) |
All Payment Transactions
858 individual payment records from CMS Open Payments — Page 1 of 35
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | LivaNova USA, Inc. | VNS THERAPY SYMMETRY MODEL 8103 GENERATOR (Device) | Food and Beverage | In-kind items and services | $25.42 | General |
| Category: Neurology | ||||||
| 12/17/2024 | LivaNova USA, Inc. | VNS THERAPY SYMMETRY MODEL 8103 GENERATOR (Device) | Food and Beverage | In-kind items and services | $103.89 | General |
| Category: Neurology | ||||||
| 12/17/2024 | LivaNova USA, Inc. | VNS THERAPY SYMMETRY MODEL 8103 GENERATOR (Device) | Food and Beverage | In-kind items and services | $30.65 | General |
| Category: Neurology | ||||||
| 12/17/2024 | LivaNova USA, Inc. | VNS THERAPY SYMMETRY MODEL 8103 GENERATOR (Device) | Food and Beverage | In-kind items and services | $14.18 | General |
| Category: Neurology | ||||||
| 12/13/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $14.41 | General |
| Category: Central Nervous System | ||||||
| 12/12/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $21.27 | General |
| Category: Psychology/Psychiatric | ||||||
| 12/10/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $20.56 | General |
| Category: PSYCHIATRY | ||||||
| 12/10/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.01 | General |
| Category: NEUROSCIENCE | ||||||
| 12/09/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $13.12 | General |
| Category: PSYCHIATRY | ||||||
| 12/09/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $1.89 | General |
| Category: PSYCHIATRY | ||||||
| 12/06/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $19.93 | General |
| Category: PSYCHIATRY | ||||||
| 12/06/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $2.40 | General |
| Category: PSYCHIATRY | ||||||
| 12/04/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $28.11 | General |
| Category: Neuroscience | ||||||
| 12/03/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $26.35 | General |
| Category: Neuropsychiatry | ||||||
| 12/03/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $8.06 | General |
| Category: Central Nervous System | ||||||
| 12/02/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $21.15 | General |
| Category: Neuroscience | ||||||
| 11/27/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $5.62 | General |
| Category: PSYCHIATRY | ||||||
| 11/26/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $6.52 | General |
| Category: Neuropsychiatry | ||||||
| 11/25/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $16.74 | General |
| Category: CNS | ||||||
| 11/22/2024 | Tris Pharma Inc | Dyanavel XR (Drug) | Food and Beverage | In-kind items and services | $23.22 | General |
| Category: ADHD | ||||||
| 11/22/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $1.60 | General |
| Category: NEUROSCIENCE | ||||||
| 11/21/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $123.75 | General |
| Category: Psychiatry/Psychology | ||||||
| 11/21/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $20.60 | General |
| Category: Psychiatry/Psychology | ||||||
| 11/21/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $0.68 | General |
| Category: Psychiatry/Psychology | ||||||
| 11/20/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.15 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 318 | 928 | $192,421 | $70,751 |
| 2022 | 4 | 114 | 447 | $97,962 | $34,533 |
| 2021 | 5 | 324 | 1,078 | $175,040 | $67,152 |
| 2020 | 6 | 443 | 1,843 | $296,945 | $114,043 |
All Medicare Procedures & Services
22 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 83 | 309 | $77,868 | $27,619 | 35.5% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2023 | 103 | 431 | $59,909 | $21,772 | 36.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 21 | 73 | $25,696 | $9,447 | 36.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 55 | 55 | $17,985 | $6,900 | 38.4% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2023 | 19 | 19 | $7,486 | $2,612 | 34.9% |
| 96132 | Evaluation of neuropsychological test, first hour | Office | 2023 | 19 | 20 | $2,700 | $1,903 | 70.5% |
| 96138 | Administration of psychological or neuropsychological test by technician, first 30 minutes | Office | 2023 | 18 | 21 | $777.00 | $496.40 | 63.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 35 | 177 | $44,604 | $16,030 | 35.9% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2022 | 36 | 202 | $28,078 | $10,009 | 35.6% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2022 | 32 | 32 | $12,608 | $4,477 | 35.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 11 | 36 | $12,672 | $4,016 | 31.7% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 93 | 476 | $85,680 | $26,571 | 31.0% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 86 | 317 | $57,060 | $25,037 | 43.9% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 45 | 47 | $8,460 | $6,336 | 74.9% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 61 | 198 | $15,840 | $5,911 | 37.3% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 39 | 40 | $8,000 | $3,297 | 41.2% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 112 | 815 | $146,640 | $45,243 | 30.9% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 103 | 472 | $84,830 | $38,358 | 45.2% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2020 | 90 | 393 | $31,440 | $12,063 | 38.4% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 64 | 71 | $12,935 | $9,974 | 77.1% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 53 | 65 | $13,000 | $5,372 | 41.3% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Facility | 2020 | 21 | 27 | $8,100 | $3,033 | 37.4% |
About Dr. Haresh Tharwani, M.D
Dr. Haresh Tharwani, M.D is a Psychiatry healthcare provider based in Cary, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/25/2006. The National Provider Identifier (NPI) number assigned to this provider is 1790869618.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Haresh Tharwani, M.D has received a total of $153,027 in payments from pharmaceutical and medical device companies, with $33,102 received in 2024. These payments were reported across 858 transactions from 34 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($105,680).
As a Medicare-enrolled provider, Tharwani has provided services to 1,199 Medicare beneficiaries, totaling 4,296 services with total Medicare billing of $286,478. Data is available for 4 years (2020–2023), covering 22 distinct procedure/service records.
Practice Information
- Specialty Psychiatry
- Location Cary, NC
- Active Since 10/25/2006
- Last Updated 04/25/2024
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1790869618
Products in Payments
- VRAYLAR (Drug) $50,854
- ABILIFY MAINTENA (Drug) $44,695
- ARISTADA (Drug) $35,431
- INGREZZA (Drug) $2,860
- REXULTI (Drug) $1,679
- CAPLYTA (Drug) $1,428
- VNS THERAPY SYMMETRY MODEL 8103 GENERATOR (Device) $803.29
- Adzenys XR-ODT (Drug) $690.63
- SPRAVATO (Drug) $680.73
- LYBALVI (Drug) $472.19
- LATUDA (Drug) $420.77
- INVEGA TRINZA (Drug) $419.73
- UZEDY (Drug) $387.72
- Austedo XR (Drug) $360.94
- AUSTEDO (Drug) $360.02
- Aristada 441 mg (Drug) $346.51
- QUVIVIQ (Drug) $325.16
- INVEGA SUSTENNA (Drug) $314.98
- HETLIOZ (Drug) $261.43
- Qelbree (Drug) $223.51
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Cary
Waheed Bajwa, M.d, M.D
Psychiatry — Payments: $24,536
Dr. Eliza Park, M.d, M.D
Psychiatry — Payments: $3,800
Tiesha Panek, Pmhnp-Bc, PMHNP-BC
Psychiatry — Payments: $3,763
Dr. Carol Martin, Md, MD
Psychiatry — Payments: $2,795
Daniel Tan, Md, MD
Psychiatry — Payments: $1,956
Dr. Stephanie Price, Do, DO
Psychiatry — Payments: $1,897